European Journal of Clinical Pharmacology

, Volume 32, Issue 6, pp 549–553 | Cite as

Assessment of ‘once daily’ verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording

  • M. Caruana
  • M. Heber
  • G. Brigden
  • E. B. Raftery


A new, slow release formulation of verapamil, “verapamil o.d.” was administered to 12 patients with essential hypertension.

Drug administration was started at a dose of 240 mg and increased to 480 mg after 2 weeks of treatment if the cuff blood pressure response was unsatisfactory.

The drug reduced the daytime intra-arterial blood pressure significantly from 180.7/106.8 mm Hg to 157.3/89.4 mm Hg. The daytime heart rate fell from 88.1 to 71.8 beats/min. The nighttime blood pressure decreased from 155.7/87.2 mm Hg to 140.5/75.3 mm Hg. The nocturnal heart rate decreased from 62.8 to 57 beats/min. Hourly plots of mean systolic and diastolic pressure showed a significant reduction of systolic pressure for 21 of 24 h and of diastolic pressure for all 24 h following a single morning dose. The drug modified the absolute blood pressure and heart-rate response during both forms of exercise, but did not alter the magnitude or rate of blood pressure change. The tilt-test produced no evidence of postural hypotension.

Only one patient experienced any side effects whilst taking the drug.

These results indicate good 24-h blood pressure control and reduced exercise blood pressure levels during treatment with this new formulation of verapamil. The reduced frequency of drug administration should improve patient complicance with treatment of hypertension.

Key words

verapamil hypertension bicycle exercise isometric hand-grip 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Livesley B, Catley PF, Campbell RC, Oram S (1973) Doubleblind evaluation of verapamil, propranolol and isosorbide dinitrate against a placebo in the treatment of angina pectoris. Br Med J 1: 375–378PubMedGoogle Scholar
  2. 2.
    Balasubramanian V, Lahiri A, Paramasivan R, Raftery EB (1980) Verapamil in chronic stable angina — a controlled study with computerised multi-stage treadmill exercise. Lancet 1: 841–844CrossRefGoogle Scholar
  3. 3.
    Krikler DM, Spurrell RA (1974) Verapamil in the treatment of paroxysmal supraventricular tachycardia. Postgrad Med J 50: 447–453PubMedCrossRefGoogle Scholar
  4. 4.
    Schamroth L, Krikler DM, Garret L (1972) Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J 660–662Google Scholar
  5. 5.
    Lewis GRJ, Morley DK, Lewis BM (1978) The treatment of hypertension with verapamil. N Zeal Med J 87: 351–354Google Scholar
  6. 6.
    Gould BA, Hornung RS, Mann S, Balasubramanian V, Raftery EB (1983) Nifedipine or verapamil as sole treatment of hypertension: An intra-arterial study. Hypertension 5 [Suppl II]: II21-II96Google Scholar
  7. 7.
    Hornung RS, Jones RI, Gould BA, Sonecha T, Raftery EB (1984) Propranolol versus verapamil for the treatment of essential hypertension. Am Heart J 108: 554–560PubMedCrossRefGoogle Scholar
  8. 8.
    Robinson BF, Collier JG, Dobbs RJ (1979) Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial beds and dorsal hand veins in man: Functional differences between vascular smooth muscles in arterioles and veins. Cardiovasc Res 13: 16–21PubMedCrossRefGoogle Scholar
  9. 9.
    Blackwell B (1973) Drug therapy: Patient compliance. N Engl J Med 289: 249–252PubMedCrossRefGoogle Scholar
  10. 10.
    Shulz E, Ha HR, Buhler FR, Follath F (1982) Serum concentration and antihypertensive effect of slow release verapamil. J Cardiovasc Pharmacol 4: S346-S349Google Scholar
  11. 11.
    Muller FB, Ha HR, Hotz H, Sohmidlen O, Follath F, Buhler FR (1986) Once a day verapamil in essential hypertension. Br J Clin Pharmacol 21: 143S-1437SPubMedGoogle Scholar
  12. 12.
    Gould BA, Mann S, Davies AB, Altman DG, Raftery EB (1982) Does placebo lower blood pressure? Lancet 2: 1377–1381Google Scholar
  13. 13.
    Millar-Craig MW, Hawes D, Whittington J (1978) A new system for recording ambulatory blood pressure in man. Med Biol Engl Comput 16: 727–731CrossRefGoogle Scholar
  14. 14.
    Cashman PMM, Millar-Craig MW, Stott FD (1979) A hybrid system for fast data reduction of long-term blood pressure recordings. Med Biol Engl Comput 17: 629–635CrossRefGoogle Scholar
  15. 15.
    Mann S, Millar-Craig MW, Balasubramanian V, Raftery EB (1970) The effects of beta-blockade an ambulatory blood pressure, modern aspects of beta-blocker therapy. Birdwood GFB, Wink CAS (eds). Geigy Pharmaceuticals, Macclesfield p 33–40Google Scholar
  16. 16.
    Caruana M, Al-Khawaja I, Prince H, Raftery EB (1986) Effects of tiapamil, a new calcium channel blocker on ambulatory intra-arterial blood pressure and exercise-induced changes in blood pressure. J Cardiovasc Pharmacol 8: 1074–1077PubMedGoogle Scholar
  17. 17.
    Sokolow M, Werdegar D, Kain H, Hinman A (1966) Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 34: 279–298PubMedGoogle Scholar
  18. 18.
    Marshall J (1977) Diurnal variation in occurrence of strokes. Stroke 8: 230–231PubMedGoogle Scholar
  19. 19.
    Tunstall Pedoe H, Clayton D, Morris J, Brigden W, McDonald L (1975) Coronary heart attacks in East London. Lancet 2: 833–838CrossRefGoogle Scholar
  20. 20.
    Jones R, Hornung R, Cashman P, Raftery EB (1985) Effect of enalapril at rest, during tilt, static and dynamic exercise in systemic hypertension. Am J Cardiol 55: 1534–1538PubMedCrossRefGoogle Scholar
  21. 21.
    Nash DT, Feer TD (1983) Hepatic injury possibly induced by verapamil. J Am Med Assoc 249: 395–396CrossRefGoogle Scholar
  22. 22.
    Guarascio P, D'Amato C, Setter P, Conte A, Visco C (1984) Liver damage from verapamil. Br Med J 288: 362–363CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • M. Caruana
    • 1
  • M. Heber
    • 1
  • G. Brigden
    • 1
  • E. B. Raftery
    • 1
  1. 1.Cardiology DepartmentNorthwick Park Hospital and Clinical Research CentreHarrowU.K.

Personalised recommendations